Myopia Progressing
7
1
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
14.3%
1 terminated out of 7 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
Different Microlenses Array for Controlling Myopia Progression in Children and Adolescents
Comparison of MiSight 1-Day and Acuvue Oasys for Presbyopia in Myopic Children
Brain Visual Perception Training for Prevention and Control of Premyopia
Topical 0.01% Atropine for the Control of Fast Progressing Myopia